NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for TORNTPHARM is Neutral → (moderate move); technical trend raise-2026-06-22; trading at ₹4,967.10 (-1.32% today); neutral (RSI 61).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Moderate move |
|---|---|
| Technical trend | RAISE-2026-06-22 |
| Price | ₹4,967.10 |
| Change today | -1.32% |
| RSI (14) | 61.00 |
| Relative volume | 0.20 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹1.84 Lakh Cr |
| P/E | 77.44 |
| Cap category | Mega Cap |
| 52-week high | -1.5% away |
| 52-week low | +43.0% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for TORNTPHARM (Torrent Pharmaceuticals Limited) is Neutral with a moderate move, and its technical trend is raise-2026-06-22. The composite score and full factor breakdown are available to signed-in members.
TORNTPHARM's RSI is neutral (RSI 61). A reading above 70 is typically overbought and below 30 oversold.
TORNTPHARM is trading about 1% below its 52-week high and 43% above its 52-week low as of Aug 14 2026, 6:50 PM.
TORNTPHARM's market capitalisation is ₹1.84 Lakh Cr as of Aug 14 2026, 6:50 PM.
TORNTPHARM is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.